RN, R., C, T., F, K., MC, C., D, S., C, R., . . . K, R. (2022). Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination. Clinical & translational immunology, 11(5), e1392. https://doi.org/10.1002/cti2.1392
Chicago Style (17th ed.) CitationRN, Ramos, et al. "Pseudocowpox Virus, a Novel Vector to Enhance the Therapeutic Efficacy of Antitumor Vaccination." Clinical & Translational Immunology 11, no. 5 (2022): e1392. https://doi.org/10.1002/cti2.1392.
MLA (9th ed.) CitationRN, Ramos, et al. "Pseudocowpox Virus, a Novel Vector to Enhance the Therapeutic Efficacy of Antitumor Vaccination." Clinical & Translational Immunology, vol. 11, no. 5, 2022, p. e1392, https://doi.org/10.1002/cti2.1392.
Warning: These citations may not always be 100% accurate.
